Company Filing History:
Years Active: 2005
Title: Greg Cope: Innovator in Protein Activity Regulation
Introduction
Greg Cope is a notable inventor based in Pasadena, CA. He has made significant contributions to the field of biochemistry, particularly in the regulation of target protein activity through modifier proteins. His innovative work has implications for drug design and therapeutic applications.
Latest Patents
Greg Cope holds a patent for the invention titled "Regulation of target protein activity through modifier proteins." This invention is based on the discovery that a polypeptide containing the JAB subunit or the JAM domain exhibits peptidase activity, specifically isopeptidase activity. The patent provides polypeptides and crystalline polypeptides containing the JAM domain, along with methods for screening agents that can affect the peptidase activity of these polypeptides. Additionally, it outlines methods for using the JAM domain in rational drug design.
Career Highlights
Greg Cope is affiliated with the California Institute of Technology, where he continues to advance research in protein activity regulation. His work is characterized by a commitment to scientific innovation and practical applications in medicine.
Collaborations
Some of his notable coworkers include Svetlana A Lyapina and Rati Verma, who contribute to the collaborative research environment at the California Institute of Technology.
Conclusion
Greg Cope's contributions to the field of protein activity regulation highlight the importance of innovative research in biochemistry. His patent and ongoing work have the potential to influence drug design and therapeutic strategies significantly.